(XERS) Xeris Pharmaceuticals - Performance 137.4% in 12m
Compare XERS with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
41.03%
#37 in Group
Rel. Strength
97.60%
#185 in Universe
Total Return 12m
137.38%
#9 in Group
Total Return 5y
199.71%
#14 in Group
P/E -
(unknown) Percentile in Group
P/E Forward -
(unknown) Percentile in Group
PEG -
(unknown) Percentile in Group
FCF Yield -3.69%
26th Percentile in Group
12m Total Return: XERS (137.4%) vs XLV (-0.6%)
5y Drawdown (Underwater) Chart
Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| LLY NYSE Eli Lilly |
-13.4% | 6.56% | 513% | 70 | 36 | 1.21 | 40.3% | 34.5% |
| IPN PA Ipsen |
-4.44% | 2.34% | 143% | 25.2 | 10.6 | 0.76 | -2.70% | -6.33% |
| SFZN SW Siegfried Holding |
-6.55% | 3.64% | 125% | 24.8 | 22.8 | 1.45 | 66.7% | 72.5% |
| NVS NYSE Novartis |
2.65% | 18.5% | 69.6% | 19 | 13.6 | 1.3 | 36.2% | 11.6% |
| SAN PA Sanofi |
-5.26% | 20% | 51.7% | 23.2 | 12.2 | 1.12 | -22.1% | -24.8% |
| SOBI ST Swedish Orphan Biovitrum |
-11% | 8.35% | 67% | 26 | 19.9 | 1.54 | 11.8% | 14.7% |
| SUPN NASDAQ Supernus Pharmaceuticals |
-0.19% | -5.49% | 82.9% | 24.5 | 20.2 | 1.47 | -20.8% | -17% |
| AZN NASDAQ AstraZeneca |
-4.6% | 10.1% | 85.2% | 34.1 | 17 | 1.07 | 43.2% | -20.1% |
Performance Comparison: XERS vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for XERS
| Total Return (including Dividends) | XERS | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 37.67% | -3.80% | -3.62% |
| 3 Months | 46.82% | 4.57% | -3.76% |
| 12 Months | 137.38% | -0.56% | 8.80% |
| 5 Years | 199.71% | 78.67% | 143.09% |
| Trend Score (consistency of price movement) | XERS | XLV | S&P 500 |
| 1 Month | 84.0% | -54.2% | -17.5% |
| 3 Months | 93.2% | 53.1% | -55.3% |
| 12 Months | 97.5% | 20.4% | 84.8% |
| 5 Years | -28.3% | 90.4% | 84.4% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
| 1 Month | #5 | 43.1% | 42.8% |
| 3 Month | #7 | 40.4% | 52.6% |
| 12 Month | #10 | 139% | 118% |
| 5 Years | #13 | 67.7% | 23.3% |
FAQs
Does XERS Xeris Pharmaceuticals outperforms the market?
Yes,
over the last 12 months XERS made 137.38%, while its related Sector, the Health Care Sector SPDR (XLV) made -0.56%.
Over the last 3 months XERS made 46.82%, while XLV made 4.57%.
Over the last 3 months XERS made 46.82%, while XLV made 4.57%.
Performance Comparison XERS vs Indeces and Sectors
XERS vs. Indices XERS is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -10.9% | 41.3% | 82.8% | 129% |
| US NASDAQ 100 | QQQ | -9.25% | 42.4% | 83.6% | 130% |
| US Dow Jones Industrial 30 | DIA | -12.0% | 40.4% | 81.8% | 130% |
| German DAX 40 | DAX | -10.9% | 40.5% | 65.0% | 115% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -11.9% | 37.4% | 91.0% | 128% |
| Hongkong Hang Seng | HSI | -13.7% | 35.2% | 87.2% | 119% |
| India NIFTY 50 | INDA | -11.6% | 30.9% | 93.7% | 138% |
| Brasil Bovespa | EWZ | -12.4% | 29.4% | 89.4% | 149% |
XERS vs. Sectors XERS is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -10.0% | 41.8% | 74.8% | 119% |
| Consumer Discretionary | XLY | -10.4% | 43.3% | 81.6% | 127% |
| Consumer Staples | XLP | -17.4% | 39.2% | 81.9% | 127% |
| Energy | XLE | -14.3% | 29.8% | 75.7% | 135% |
| Financial | XLF | -12.1% | 41.2% | 70.9% | 117% |
| Health Care | XLV | -12.1% | 41.5% | 87.7% | 138% |
| Industrial | XLI | -11.5% | 39.3% | 84.0% | 130% |
| Materials | XLB | -13.2% | 38.0% | 91.4% | 142% |
| Real Estate | XLRE | -14.8% | 40.8% | 86.1% | 126% |
| Technology | XLK | -8.72% | 42.4% | 87.3% | 137% |
| Utilities | XLU | -16.2% | 37.3% | 83.5% | 113% |
| Aerospace & Defense | XAR | -8.60% | 38.0% | 79.7% | 120% |
| Biotech | XBI | -3.22% | 46.4% | 102% | 154% |
| Homebuilder | XHB | -11.0% | 39.2% | 104% | 148% |
| Retail | XRT | -12.5% | 40.3% | 89.6% | 147% |